Inventor · disambiguated record
Jenny Mcintosh
Also filed as: MCINTOSH JENNY
14 granted patents·8 pending applications·62 citations·filing 2013–2025
90Inventor score
Files withUCL BUSINESS LTD8BIOMARIN PHARM INC5UCL BUSINESS PLC5FREELINE THERAPEUTICS LTD3SPUR THERAPEUTICS LTD1
Top patents by PatentIndex Score
22 records- 0196US9504762B2Adeno-associated virus factor VIII vectorsBIOMARIN PHARM INC·Filed 2014·Granted Nov 29, 2016·28 cites·9 claims
- 0296US9447168B2Nucleic acid molecules encoding modified factor VIII proteinsUCL BUSINESS PLC·Filed 2013·Granted Sep 20, 2016·18 cites·8 claims
- 0390US10124041B2Methods of delivering factor VIII encoding nucleic acid sequencesUCL BUSINESS PLC·Filed 2016·Granted Nov 13, 2018·4 cites·8 claims
- 0488US2025108093A1Factor VIII SequencesUCL BUSINESS LTD·Filed 2024·Application pending·0 cites
- 0587US11517631B2Factor IX encoding nucleotidesUCL BUSINESS LTD·Filed 2019·Granted Dec 6, 2022·2 cites·14 claims
- 0687US10792336B2Method of treating hemophilia AUCL BUSINESS PLC·Filed 2018·Granted Oct 6, 2020·2 cites·12 claims
- 0785US10463718B2Adeno-associated virus factor VIII vectorsBIOMARIN PHARM INC·Filed 2016·Granted Nov 5, 2019·3 cites·10 claims
- 0885US10413598B2Factor IX gene therapyUCL BUSINESS PLC·Filed 2015·Granted Sep 17, 2019·3 cites·20 claims
- 0983US12239692B2Adeno-associated virus factor VIII vectorsBIOMARIN PHARM INC·Filed 2022·Granted Mar 4, 2025·0 cites·5 claims
- 1080US2023241180A1Factor VIII SequencesUCL BUSINESS LTD·Filed 2022·Application pending·0 cites
- 1179US10842885B2Factor IX encoding nucleotidesUCL BUSINESS LTD·Filed 2018·Granted Nov 24, 2020·2 cites·24 claims
- 1276US11406690B2Adeno-associated virus factor VIII vectorsBIOMARIN PHARM INC·Filed 2019·Granted Aug 9, 2022·0 cites·5 claims
- 1376US2025332224A1Adeno-Associated Virus Factor VIII VectorsBIOMARIN PHARM INC·Filed 2025·Application pending·0 cites
- 1474US11419920B2Factor VIII sequencesUCL BUSINESS LTD·Filed 2020·Granted Aug 23, 2022·0 cites·9 claims
- 1569US2022331409A1Factor ix gene therapyUCL BUSINESS LTD·Filed 2022·Application pending·0 cites
- 1668US11344608B2Factor IX gene therapyUCL BUSINESS LTD·Filed 2019·Granted May 31, 2022·0 cites·14 claims
- 1766US12209262B2Factor IX encoding nucleotidesUCL BUSINESS LTD·Filed 2019·Granted Jan 28, 2025·0 cites·20 claims
- 1862US2018161403A1Adeno-associated virus factor viii vectorsUCL BUSINESS PLC·Filed 2017·Application pending·0 cites
- 1956US2022396611A1Factor viii constructFREELINE THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 2054US2022396610A1Factor viii polypeptideFREELINE THERAPEUTICS LTD·Filed 2020·Application pending·0 cites
- 2150US2024261433A1PolypeptideFREELINE THERAPEUTICS LTD·Filed 2021·Application pending·0 cites
- 2248US12331331B2PolynucleotidesSPUR THERAPEUTICS LTD·Filed 2020·Granted Jun 17, 2025·0 cites·7 claims
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →